Skip to main content
2024 Canadian Cardiovascular Congress Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Handout
Handout
Networking
Networking
On-Demand
On-Demand
Early Career Involvement
Early Career Involvement
Back
Session Evaluation

CORONARY ARTERY DISEASE - GENERAL

IMAGING

COMMUNITY

CLINICAL

EARLY CAREER INVOLVEMENT

255 - PERICARDIAL DISEASES FOR THE GENERAL CARDIOLOGIST: EVERYTHING YOU NEED TO KNOW ABOUT THE MODERN MEDICAL AND SURGICAL MANAGEMENT OF PERICARDIAL DISEASE

Friday, October 25, 2024
3:15 PM – 4:15 PM PT
Room: 212-213
Early Career Involvement
Workshop Description: Pericarditis is a common inflammatory disorder involving the pericardium and is a significant source of morbidity for patients. Importantly, a common problem with pericarditis is disease recurrence; of those that have an episode of acute pericarditis, 15-30% will go on to have further recurrence of the disease, with 50% having multiple recurrences. These disease recurrences cause significant morbidity to patients and can be a substantial burden on the healthcare system, requiring emergency department visits and possible admissions to hospital. Advanced cardiac imaging techniques, such as cardiac MRI are revolutionizing how we can image the inflamed pericardium, and novel therapeutics are quickly changing how we treat this disease process.

In this workshop, we will provide the audience with a broad overview of many of the new and important developments in the field of pericardial diseases. This will include presentations from: (i) a cardiac surgeon with expertise in the surgical management of pericardial diseases. (ii) a multi-modality advanced imaging cardiologist with experience in the new developments of pericardial imaging who will explain recent important developments in imaging for pericardial disease including image-guided treatments. ( (iii) a cardiology trainee who will provide an overview on the novel treatments available for the treatment of inflammatory pericardial diseases. (iv) a rheumatologist will give an overview of the practical aspects of starting and monitoring immunomodulatory therapies for pericardial diseases. This workshop is both timely and novel and should appeal to all health care providers in cardiology given the surprising prevalence of pericardial diseases.

Interactive and Engagement Activities Description: The welcome and introduction period will use audience polls to test general knowledge about pericardial disorders.

Each presenter will include 3 minutes of live polling during their presentation for audience participation (4 presenters x 3 minutes = 12 minutes).

There will be a 10-minute Question and Answer period at the end of the session where the audience will be invited to ask questions to the panel members (made up of the chair, co-chair and presenters).

Learning Objectives:

At the end of this session participants will be able to:
  • identify patients with common pericardial conditions and develop effective strategies to assist with and advocate for their care;
  • outline the available advanced imaging modalities to assist in the diagnosis and management of pericardial diseases;
  • understand the surgical management of pericardial diseases;
  • understand the novel treatments available for pericardial diseases and when to refer to a regional center of excellence; and
  • develop an approach for appropriate screening and monitoring of anti-cytokine and colchicine therapy and understand the potential serious adverse events of these therapies.
Disclosure(s):
Kevin Boczar, MD, FRCPC: MedTrace: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Novartis: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Novo Nordisk: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
Michael Chetrit, MD FRCPC: Alnylam: Honoraria (Ongoing); BMS: Small Grant for QI (Ongoing), Speaker Honoraria (Ongoing); Pfizer: Advisory Board (Ongoing), Hororaria (Ongoing), Small grant for research (Ongoing)
Bindee Kuriya, MD, FRCPC, SM: Abbvie: Serve as member on national advisory board meetings (Ongoing); Pfizer: Member on national ad boards (Ongoing)
Jean-Simon Lalancette, MD FRCPC: No financial relationships to disclose
Hadi Toeg, MD FRCSC: No financial relationships to disclose
Melissa Fay Lepage-Ratte, MD FRCPC: No financial relationships to disclose
Maria Lopez Laporte, MD: No financial relationships to disclose
Bethlehem Mengesha, MD: No financial relationships to disclose
Shadi Akhtari, MD, MSc, FRCPC, FACC: abbvie: Speaker/Honoraria (Terminated, December 31, 2022); Novartis: Speaker/Honoraria (Terminated, December 31, 2023)
Paula J. Harvey, BMBS, PhD, FRACP: Abbvie: honoraria for CME talk on Rheumatic Diseases and cardiovascular risk (Terminated, May 31, 2023); UPharmacy conferenc, BIOS supported the session: honoraria for CME talk on Women's Cardiovascular Health (Terminated, April 1, 2023)
Oluwatosin Osuntokun, MB BCh BAo: No financial relationships to disclose